10.21147/j.issn.1000-9604.2022.03.02
National guidelines for diagnosis and treatment of breast cancer 2022 in China(English version)
Contents
1.Breast cancer screening
1.1 Recommendations for females at normal risk
1.1.1 Age 20-39 years old
1.1.2 Age 40-69 years old
1.1.3 Age>70 years old
1.2 Recommendations for females at increased risk
2.Diagnosis of breast cancer
2.1 Clinical manifestations
2.1.1 Breast lump
2.1.2 Nipple discharge
2.1.3 Skin changes
2.1.4 Abnormalities in nipple and areola
2.1.5 Enlarged axillary lymph nodes
2.2 Breast palpation
2.3 Imaging tests
2.3.1 Mammography
2.3.2 Breast ultrasound
2.3.3 Breast MRI
2.3.4 Positron emission tomography-computed tomography(PET-CT)
2.3.5 Bone scan
2.4 Laboratory tests
2.4.1 Blood chemistry
2.4.2 Tumor markers
3.Pathological diagnosis
3.1 Specimen type and fixation
3.1.1 Specimen type
3.1.2 Specimen fixation
3.2 Specimen dissection and gross description
3.2.1 Core needle biopsy specimen
3.2.2 Vacuum-assisted biopsy specimen(mammotome minimally invasive surgery specimen)
3.2.3 Lumpectomy specimen
3.2.4 BCS specimen
3.2.5 Mastectomy specimen
3.2.6 Sentinel lymph node biopsy(SLNB)
national、english、cancer、china、breast、diagnosis、guidelines、treatment、version
34
S;H313;G2
2022-08-09(万方平台首次上网日期,不代表论文的发表时间)
共25页
151-175